Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 5
2005 1
2006 5
2007 3
2008 5
2009 4
2010 3
2011 6
2012 7
2013 4
2014 7
2015 7
2016 6
2017 3
2018 11
2019 10
2020 5
2021 6
2022 9
2023 7
2024 11
2025 11
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
ARGX-117, a therapeutic complement inhibiting antibody targeting C2.
Van de Walle I, Silence K, Budding K, Van de Ven L, Dijkxhoorn K, de Zeeuw E, Yildiz C, Gabriels S, Percier JM, Wildemann J, Meeldijk J, Simons PJ, Boon L, Cox L, Holgate R, Urbanus R, Otten HG, Leusen JHW, Blanchetot C, de Haard H, Hack CE, Boross P. Van de Walle I, et al. Among authors: leusen jhw. J Allergy Clin Immunol. 2021 Apr;147(4):1420-1429.e7. doi: 10.1016/j.jaci.2020.08.028. Epub 2020 Sep 11. J Allergy Clin Immunol. 2021. PMID: 32926878 Free PMC article.
IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models.
Stip MC, Evers M, Nederend M, Chan C, Reiding KR, Damen MJ, Heck AJR, Koustoulidou S, Ramakers R, Krijger GC, de Roos R, Souteyrand E, Cornel AM, Dierselhuis MP, Jansen M, de Boer M, Valerius T, van Tetering G, Leusen JHW, Meyer-Wentrup F. Stip MC, et al. Among authors: leusen jhw. J Immunother Cancer. 2023 Jul;11(7):e006948. doi: 10.1136/jitc-2023-006948. J Immunother Cancer. 2023. PMID: 37479484 Free PMC article.
Targeting the myeloid microenvironment in neuroblastoma.
Stip MC, Teeuwen L, Dierselhuis MP, Leusen JHW, Krijgsman D. Stip MC, et al. Among authors: leusen jhw. J Exp Clin Cancer Res. 2023 Dec 13;42(1):337. doi: 10.1186/s13046-023-02913-9. J Exp Clin Cancer Res. 2023. PMID: 38087370 Free PMC article. Review.
IgA as therapeutic antibody.
Leusen JH. Leusen JH. Mol Immunol. 2015 Nov;68(1):35-9. doi: 10.1016/j.molimm.2015.09.005. Mol Immunol. 2015. PMID: 26597204 Review.
Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy.
Budding K, Johansen LE, Van de Walle I, Dijkxhoorn K, de Zeeuw E, Bloemenkamp LM, Bos JW, Jansen MD, Curial CAD, Silence K, de Haard H, Blanchetot C, Van de Ven L, Leusen JHW, Pasterkamp RJ, van den Berg LH, Hack CE, Boross P, van der Pol WL. Budding K, et al. Among authors: leusen jhw. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 10;9(1):e1107. doi: 10.1212/NXI.0000000000001107. Print 2022 Jan. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34759020 Free PMC article.
ITPK1 Sensitizes Tumor Cells to IgA-dependent Neutrophil Killing In Vivo.
Richterich CA, Logtenberg MEW, Jansen MJH, Toebes M, Bresser K, Borst A, Jurgens AP, Leusen JHW, Schumacher TN. Richterich CA, et al. Among authors: leusen jhw. J Immunol. 2024 Oct 15;213(8):1244-1254. doi: 10.4049/jimmunol.2300372. J Immunol. 2024. PMID: 39213127 Free PMC article.
Identification of a tumor-specific allo-HLA-restricted γδTCR.
Kierkels GJJ, Scheper W, Meringa AD, Johanna I, Beringer DX, Janssen A, Schiffler M, Aarts-Riemens T, Kramer L, Straetemans T, Heijhuurs S, Leusen JHW, San José E, Fuchs K, Griffioen M, Falkenburg JH, Bongiovanni L, de Bruin A, Vargas-Diaz D, Altelaar M, Heck AJR, Shultz LD, Ishikawa F, Nishimura MI, Sebestyén Z, Kuball J. Kierkels GJJ, et al. Among authors: leusen jhw. Blood Adv. 2019 Oct 8;3(19):2870-2882. doi: 10.1182/bloodadvances.2019032409. Blood Adv. 2019. PMID: 31585951 Free PMC article.
Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade.
Constantinides A, Lansu N, Mosen P, Rauwerdink P, Strating E, Völlmy F, Nederend M, Leusen JHW, Rovers K, Wassenaar E, Lurvink R, Altelaar M, Nienhuijs S, Wiezer R, Borel Rinkes IHM, Boerma D, Kops GJPL, de Hingh I, Kranenburg O. Constantinides A, et al. Among authors: leusen jhw. Transl Oncol. 2025 Sep;59:102464. doi: 10.1016/j.tranon.2025.102464. Epub 2025 Jul 1. Transl Oncol. 2025. PMID: 40602034 Free PMC article.
127 results